Maria Sarasa

ORCID: 0000-0003-4429-7945
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Chemokine receptors and signaling
  • Multiple Myeloma Research and Treatments
  • Protein Degradation and Inhibitors
  • Immunotherapy and Immune Responses

Abstract Purpose: Early intervention in smoldering multiple myeloma (SMM) requires optimal risk stratification to avoid under- and overtreatment. We hypothesized that replacing bone marrow (BM) plasma cells (PC) for circulating tumor (CTC), adding immune biomarkers peripheral blood (PB) the identification of patients at progression due lost surveillance, could improve International Myeloma Working Group 20/2/20 model. Experimental Design: report outcomes 150 with SMM enrolled iMMunocell...

10.1158/1078-0432.ccr-22-1594 article EN cc-by Clinical Cancer Research 2022-09-08

<div>AbstractPurpose:<p>Early intervention in smoldering multiple myeloma (SMM) requires optimal risk stratification to avoid under- and overtreatment. We hypothesized that replacing bone marrow (BM) plasma cells (PC) for circulating tumor (CTC), adding immune biomarkers peripheral blood (PB) the identification of patients at progression due lost surveillance, could improve International Myeloma Working Group 20/2/20 model.</p>Experimental Design:<p>We report outcomes...

10.1158/1078-0432.c.6532880 preprint EN 2023-04-01
Coming Soon ...